Regarding genetic alterations, TP53 and/or CDKN2A mutations and deletions are frequently observed and form a distinct molecular subtype in PTCL-NOS (33), (34), (35). This evidence concerns the gene CDKN2A and mature T-cell and NK-cell non-Hodgkin lymphoma.